Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck’s $8.4 Billion Deal for Cubist Looks $2 Billion Too Expensive Now
Merck’s $8.4 Billion Deal for Cubist Looks $2 Billion Too Expensive Now
Merck’s $8.4 Billion Deal for Cubist Looks $2 Billion Too Expensive Now
Submitted by
admin
on December 10, 2014 - 8:13am
Source:
WSJ Online
News Tags:
Merck
Cubist Pharma
M&A
Cubicin
antibiotics
Headline:
Merck’s $8.4 Billion Deal for Cubist Looks $2 Billion Too Expensive Now
Do Not Allow Advertisers to Use My Personal information
